Kammerer-Jacquet, Solène-Florence <br/><br/>
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression.  [electronic resource] 

 -  Clinical genitourinary cancer  06 2019 
 - 169-176.e1 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0682 
<br/><br/><label>Standard No.: </label>10.1016/j.clgc.2019.01.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>B7-H1 Antigen--metabolism<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease Progression<br/>Down-Regulation<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Phenotype<br/>Retrospective Studies<br/>Sunitinib--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome<br/>Von Hippel-Lindau Tumor Suppressor Protein--genetics